Pierre Lavertu, MD
Otolaryngology · Cleveland, OHNPI 1659301943
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (39.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Synthes GmbH accounts for 66.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $3,046 and has fallen 98.7% since, to $41 in 2025.
Across 19 payments — averaging $198.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Synthes GmbH$3K
- Kls-martin L.p.$531
- Covidien LP$327
- Baxter Healthcare$97
- GSK$84
- Kerecis Limited$84
- plus $151 from 3 others
What the payments were for
- Consulting fees$3259%
- Speaking & faculty fees$1,50040%
- Travel & lodging$79421%
- Food & beverage$1,15631%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Synthes GmbH | 3 | $2,500 |
| Kls-martin L.p. | 7 | $531 |
| Covidien LP | 2 | $327 |
| Baxter Healthcare | 1 | $97 |
| GSK | 1 | $84 |
| Kerecis Limited | 1 | $84 |
| Checkpoint Surgical, Inc | 1 | $81 |
| Stryker | 1 | $40 |
| Johnson & Johnson | 2 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LigaSure$325
How this compares
$3,775 in reported general payments places this provider in the 80th percentile of 380 otolaryngology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 156 | $1,854 |
| Omeprazole | 70 | $1,580 |
| Pentoxifylline | 16 | $1,412 |
| Ipratropium Bromide | 16 | $937 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 40 | $574 |
| Fluticasone Propionate | 48 | $511 |
| Oxycodone Hcl | 37 | $323 |
| Doxycycline Monohydrate | 13 | $255 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Cleveland
- Raj SindwaniCleveland$598K
- Mark MehleCleveland$403K
- Troy WoodardCleveland$392K
- Sanjeet RangarajanCleveland$113K
- Rod RezaeeCleveland$54K
- Michael BenningerCleveland$32K
- Cameron WickCleveland$21K
- Kyra OsborneCleveland$14K
- Daniel AlamCleveland$11K
- Mohamad ChaabanCleveland$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.